0001005201-19-000080.txt : 20190509
0001005201-19-000080.hdr.sgml : 20190509
20190509182624
ACCESSION NUMBER: 0001005201-19-000080
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190509
FILED AS OF DATE: 20190509
DATE AS OF CHANGE: 20190509
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCKEE WILLIAM
CENTRAL INDEX KEY: 0001237262
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13111
FILM NUMBER: 19812202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Assertio Therapeutics, Inc
CENTRAL INDEX KEY: 0001005201
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943229046
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 SOUTH SAUNDERS RD
STREET 2: SUITE 300
CITY: LAKE FOREST
STATE: IL
ZIP: 60045
BUSINESS PHONE: (224) 419-7106
MAIL ADDRESS:
STREET 1: 100 SOUTH SAUNDERS RD
STREET 2: SUITE 300
CITY: LAKE FOREST
STATE: IL
ZIP: 60045
FORMER COMPANY:
FORMER CONFORMED NAME: DEPOMED INC
DATE OF NAME CHANGE: 19970408
4
1
wf-form4_155744076923920.xml
FORM 4
X0306
4
2019-05-09
0
0001005201
Assertio Therapeutics, Inc
ASRT
0001237262
MCKEE WILLIAM
ASSERTIO THERAPEUTICS, INC.
100 SOUTH SAUNDERS ROAD, SUITE 300
LAKE FOREST
IL
60045
1
0
0
0
Common Stock
2019-05-09
4
S
0
12500
4.6959
D
67846
D
The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2019.
The price reported is a weighted average sale price. The shares were sold in multiple same-way transactions on May 9, 2019 at prices ranging from $4.50 to $4.90 per share of common stock. If requested by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, the reporting person will provide full information regarding the number of shares of common stock sold at each separate price.
/s/ Erin R. McQuade, attorney in fact
2019-05-09